Home›Stock Screener›Granules›Quarterly Results

Granules Quarterly Results

Latest Quarter Net Profit
₹182 Cr
QSept 2026
Quarterly Results

Granules quarterly results. In Sept 2026, Granules (GRANULES) reported revenue ₹1,549 Cr and net profit ₹182 Cr — revenue +19.7% YoY. Also explore GRANULES share price charts to track price trends across different timeframes.

GRANULES Quarterly Results — Revenue, Profit & EPS Highlights

Granules latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Granules screener.

  • Revenue of ₹1,549 Cr in Sept 2026 (+4.5% vs Mar 2026, +19.7% vs Sept 2025)
  • Net Profit of ₹182 Cr in Sept 2026 (-9.9% vs Mar 2026, +38.9% vs Sept 2025)
  • EBITDA of ₹327 Cr in Sept 2026 (-10.2% vs Mar 2026)
  • Operating Margin of 21.0% in Sept 2026 (-2.0pp vs Mar 2026)
  • Earnings Per Share of ₹7.22 in Sept 2026 (-12.3% vs Mar 2026)

Granules Quarterly Results — Revenue, EBITDA, Net Profit & EPS

GRANULES quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 1,549 1,482 1,467 1,294 1,230 4.5% 19.7%
Net Profit (₹ Cr) 182 202 180 131 152 - -
EBITDA (₹ Cr) 327 364 329 275 284 - -
EPS (₹) 7.22 8.23 7.26 5.38 6.27 - -
Operating Margin (%) 21.0% 23.0% 22.0% 21.0% 21.0% - -

GRANULES Share Price Trend — 1-Year Movement Across Quarterly Results

Granules 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View GRANULES 52-week chart for the annual high/low range and current price position.

Profitability Ratios

Profit Margin 11.7%
EBITDA Margin 21.1%
Operating Margin 21.0%
ROE (Annual) 14.3%

Balance Sheet Highlights

Total Assets ₹7,720 Cr
Total Equity ₹5,085 Cr
Current Assets ₹ Cr
Current Liabilities ₹543 Cr

Cash Flow Analysis

Operating Cash Flow ₹793 Cr
Investing Cash Flow ₹-758 Cr
Financing Cash Flow ₹379 Cr
Net Cash Flow ₹414 Cr

Current Market Data

Current Price ₹801.20
Exchange NSE
Last Updated Nov 19, 2026

GRANULES vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Granules latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores